Small Compact Drives: Sondrel has been raised by Neuralink connection rumors

They are AIM-listed microchip fish Sundrill Coming to a brain transplant near you?

That’s the rumor that spread through the media this week, after the Daily Mail, citing a “source familiar with the matter,” revealed that Sondrel played a key role in developing Tesla CEO Elon Musk’s Neuralink brain-computer interface.

According to sources, Musk invited Sondrel to lend its highly specialized knowledge of custom microchip designs to Neuralink, which were successfully implanted in a patient’s brain for the first time last Sunday.

Sondrel was not drawn into confirming or denying the report, although it reminded the market that it is “one of the few companies capable of designing and supplying complex, high-specification chips built on the most advanced semiconductor technologies.”

“The group does not comment on the identity of customers,” Sondrel said. However, Sondrel has a “tier one automotive supplier” on its books.

Big link: The Daily Mail revealed, citing

Big Link: The Daily Mail, citing a “source familiar with the matter,” revealed that Sondrel played a key role in developing Elon Musk’s Neuralink brain-computer interface.

Tesla? Elon Musk? Neuralink? chip? It’s a game of market speculation bingo. No wonder Sondrel shares are up 160 percent this week.

As for the broader small market, the AIM All-Share index ended the week down half a percentage point at 750.8, an underperformance against the FTSE 100’s 0.2 per cent decline.

Blue chips were particularly affected by poor performance from AstraZeneca, Persimmon And SSE.

It was another story across the pond – as the S&P 500 hit all-time highs, approaching 5,000 for the first time ever. You won’t be surprised to learn that Magnificent 7 shares Nvidia, Microsoft, and Facebook parent Meta led the charge.

Go back to London, Artemis Resources Limited The company led this mining mission after identifying the presence of lithium-containing spodumene mineralization at its Mare Lithium Prospect in the Western Pilbara region of Western Australia.

As a result, Artemis’s stock price rose by 77 percent.

Strategic Metals Company It also had a bumper week with a major contract win that could drag down revenues in the current fiscal year.

The company said that the new customer has signed up and is expected to receive between 5,000 and 7,000 tons of iron ore annually. Shares rose more than 28 percent as a result.

Hemogenex Pharmaceuticals Company He was one of the big movers in biotechnology. The stock rose 28 percent over the week on news that the company’s trials of its HEMO-CAR-T myeloid leukemia treatment could continue.

The US Food and Drug Administration gave the green light to continue the trial after successfully addressing issues identified in June.

In the same week that Viagra was discovered to reduce the risk of Alzheimer’s disease in men, the creator of erectile dysfunction listed on AIM Future Medical Company It enjoyed a 40 percent rise in its market value after the trading update.

Investors have hailed a pivotal year in Futura’s commercial journey, which saw the successful launch of Eroxone, an over-the-counter treatment for erectile dysfunction (ED), and approval of the product in the US.

The first launch of the product, a fast-acting gel, was made in the UK and Belgium, under a deal with Cooper Consumer Health, and has exceeded expectations, capturing more than 20 per cent market share in these regions within the first year.

In-game advertising company Bedstack Group plc He had little to no avail after a £2.4m loan agreement with strategic investor Irdeto came into doubt.

In a trading update, the group said it was “keen to continue working with Irdeto as previously announced”, but the board “feels it should also consider other financing alternatives”.

As a result, Bedstack has appointed restructuring advisors to consider all options regarding the future of the group, including the potential sale of the company’s assets. Shares fell 60 percent.

Kenovo plc Its shares fell by 14 percent after the specialized real estate services company warned that several delays had led to higher costs for its older projects.

Baines Creek Group PLC It was reduced by a third after the group revealed that chief executive Adam Wilson would step down. Wilson said he will stay on until a suitable replacement is found.

The group also announced a new loan with major shareholder Avani to give it additional working capital.

Bens Creek’s operations in West Virginia were exposed to severe weather conditions earlier this year. While the mine returned to production, several trains scheduled to collect contracted coal sales were delayed, resulting in a significant backlog in coal deliveries since the beginning of the year.

Other AIM launchers included Hardid Companydown 25 percent on cash runway concerns, and Digital 9 Infrastructure Companydown a painful 40 percent after Icelandic regulators imposed a ban on a planned spin-off pending a Phase 2 investigation.

Some links in this article may be affiliate links. If you click on them we may earn a small commission. This helps us fund This Is Money, and keep it free to use. We do not write articles to promote products. We do not allow any commercial relationship to influence our editorial independence.

(Signs for translation) Daily Mail

Leave a Reply

Your email address will not be published. Required fields are marked *